Oncolytic Virus Clinical Trial for Neuroendocrine Tumor Patients Begins at Uppsala University, Sweden
It is with great excitement that we share the announcement of the start of the AdVince clinical trial for neuroendocrine cancer patients at Uppsala University in Sweden – the oncolytic virus is on its way to the first patient in the trial!!
News and Notes for the Carcinoid and Neuroendocrine Tumor Community, March 2016
Breaking News from Advanced Accelerator Applications (AAA) about PRRT Treatment— Advanced Accelerator Applications announced on March 23 that the company has initiated an expanded access program (EAP) in the United States for the investigational…READ MORE
New and Improved App for Managing Carcinoid Cancer and Neuroendocrine Tumors
Have you heard about or downloaded the Carcinoid NETs Health Storylines self-care app? Originally launched last year, the app has been updated recently with lots of improvements based on your feedback!
Developed in partnership with the Carcinoid Cancer…READ MORE
Trader Joe’s Saved My Life: Steven Muller’s Story
The combination of a lengthy road-bike ride, a recovery drink mix, and dried figs from Trader Joe’s led to a health crisis for Steven Muller and a subsequent diagnosis of a neuroendocrine tumor (NET) in his small intestine. Neuroendocrine tumors, including…READ MORE
April Luncheon with the Experts in White Plains, NY — Carcinoid and Neuroendocrine Tumor Patients Are Invited!
The Big Apple NETs support group invites you to join fellow carcinoid and neuroendocrine tumor (NET) patients and 3 medical experts for Lunch with the Experts on Sunday, April 3, 2016 at 12:00 pm at the Westchester Hills Golf Club, 401 Ridgeway Avenue, …READ MORE
Neuroendocrine Tumors to Be Focus of Presentations and Posters at ASCO Gastrointestinal Cancers Symposium
Presentations on recent advances in the treatment of neuroendocrine tumors (NETs) and new findings from the NETTER-1 clinical study on PRRT with Lutathera along with posters on a wide variety of subjects about NETs will be part of the program during the…READ MORE
10 Highlights of the Year 2015 for the Carcinoid and Neuroendocrine Tumor Community
As we begin a new year, the Carcinoid Cancer Foundation looks back on the highlights of 2015 and to a future that we hope will bring greater awareness of carcinoid and neuroendocrine cancers, earlier diagnosis for patients, new treatment options, and …READ MORE
Neuroendocrine Tumors Focus of Upcoming Issue of Hematology/Oncology Clinics
Neuroendocrine Tumors will be featured in the February 2016 issue of Hematology/Oncology Clinics. Dr. Jennifer Chan and Dr. Matthew Kulke, both from Dana-Farber Cancer Institute in Boston, Massachusetts are Editors of the issue, published by Elsevier.…READ MORE
December Luncheon with the Experts in New York City for the Carcinoid and Neuroendocrine Tumor Community
Carcinoid and neuroendocrine tumor (NET) patients have a unique opportunity to hear from three medical experts during Lunch with the Experts in New York City on Sunday, December 6, 2015. This special program was initiated and is sponsored by the Big Apple…READ MORE